The chromosome 9p21 variant not predicting long-term cardiovascular mortality in Chinese with established coronary artery disease: An eleven-year follow-up study

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lee, I Te ^a,b,c   Goodarzi, Mark O ^d   Lee, Wen Jane ^a   Rotter, Jerome I ^d   Chen, Yii Der Ida ^d   Liang, Kae Woei ^a   Lee, Wen Lieng ^a   Sheu, Wayne H H ^a,b,c  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHINESE; CHROMOSOME 9P; CHROMOSOME 9P21; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GENOTYPE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROPORTIONAL HAZARDS MODEL; THORAX PAIN; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASE; CHINA; CHROMOSOME 9; GENETICS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CHINA; CHROMOSOMES, HUMAN, PAIR 9; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS;

EID: 84899542050     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/626907     Document Type: Article

References (49)

1. Lozano R., Naghavi M., Foreman K., Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2013 380 9859 2095 2128
2. Zdravkovic S., Wienke A., Pedersen N. L., Marenberg M. E., Yashin A. I., De Faire U., Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. Journal of Internal Medicine 2002 252 3 247 254 2-s2.0-0036378360 10.1046/j.1365-2796.2002.01029.x
3. Zhou L., Zhang X., He M., Cheng L., Chen Y., Hu F. B., Wu T., Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 11 2085 2089 2-s2.0-55449112465 10.1161/ATVBAHA.108.176065
4. Zhang Q., Wang X.-F., Cheng S.-S., Wan X.-H., Cao F.-F., Li L., Chen X.-D., Liu W.-J., Yang X.-C., Jin L., Three SNPs on chromosome 9p21 confer increased risk of myocardial infarction in Chinese subjects. Atherosclerosis 2009 207 1 26 28 2-s2.0-70350759407 10.1016/j.atherosclerosis.2009.04.017
5. Guo J., Li W., Wu Z., Cheng X., Wang Y., Chen T., Association between 9p21. 3 genomic markers and coronary artery disease in East Asians: a meta-analysis involving 9, 813 cases and 10, 710 controls. Molecular Biology Reports 2013 40 1 337 343 10.1007/s11033-012-2066-1
6. Gong Y., Beitelshees A. L., Cooper-DeHoff R. M., Lobmeyer M. T., Langaee T. Y., Wu J., Cresci S., Province M. A., Spertus J. A., Pepine C. J., Johnson J. A., Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease. Circulation: Cardiovascular Genetics 2011 4 2 169 178 2-s2.0-79959710790 10.1161/CIRCGENETICS.110.959296
7. Assimes T. L., Knowles J. W., Basu A., Iribarren C., Southwick A., Tang H., Absher D., Li J., Fair J. M., Rubin G. D., Sidney S., Fortmann S. P., Go A. S., Hlatky M. A., Myers R. M., Risch N., Quertermous T., Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Human Molecular Genetics 2008 17 15 2320 2328 2-s2.0-48049115182 10.1093/hmg/ddn132
8. McPherson R., Pertsemlidis A., Kavaslar N., Stewart A., Roberts R., Cox D. R., Hinds D. A., Pennacchio L. A., Tybjaerg-Hansen A., Folsom A. R., Boerwinkle E., Hobbs H. H., Cohen J. C., A common allele on chromosome 9 associated with coronary heart disease. Science 2007 316 5830 1488 1491 2-s2.0-34249996115 10.1126/science.1142447 (Pubitemid 46906617)
9. Kathiresan S., Voight B. F., Purcell S., Musunuru K., Ardissino D., Mannucci P. M., Anand S., Engert J. C., Samani N. J., Schunkert H., Erdmann J., Reilly M. P., Rader D. J., Morgan T., Spertus J. A., Stoll M., Girelli D., McKeown P. P., Patterson C. C., Siscovick D. S., O'Donnell C. J., Elosua R., Peltonen L., Salomaa V., Schwartz S. M., Melander O., Altshuler D., Merlini P. A., Berzuini C., Bernardinelli L., Peyvandi F., Tubaro M., Celli P., Ferrario M., Fetiveau R., Marziliano N., Casari G., Galli M., Ribichini F., Rossi M., Bernardi F., Zonzin P., Piazza A., Yee J., Friedlander Y., Marrugat J., Lucas G., Subirana I., Sala J., Ramos R., Meigs J. B., Williams G., Nathan D. M., MacRae C. A., Havulinna A. S., Berglund G., Hirschhorn J. N., Asselta R., Duga S., Spreafico M., Daly M. J., Nemesh J., Korn J. M., McCarroll S. A., Surti A., Guiducci C., Gianniny L., Mirel D., Parkin M., Burtt N., Gabriel S. B., Thompson J. R., Braund P. S., Wright B. J., Balmforth A. J., Ball S. G., Hall A. S., Linsel-Nitschke P., Lieb W., Ziegler A., König I. R., Hengstenberg C., Fischer M., Stark K., Grosshennig A., Preuss M., Wichmann H.-E., Schreiber S., Ouwehand W., Deloukas P., Scholz M., Cambien F., Cardiogenics C., Li M., Chen Z., Wilensky R., Matthai W., Qasim A., Hakonarson H. H., Devaney J., Burnett M.-S., Pichard A. D., Kent K. M., Satler L., Lindsay J. M., Waksman R., Epstein S. E., Scheffold T., Berger K., Huge A., Martinelli N., Olivieri O., Corrocher R., Hólm H., Thorleifsson G., Thorsteinsdottir U., Stefansson K., Do R., Xie C., Siscovick D., Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nature Genetics 2009 41 3 334 341 2-s2.0-70749096913 10.1038/ng.327
10. Qi L., Ma J., Qi Q., Hartiala J., Allayee H., Campos H., Genetic risk score and risk of myocardial infarction in hispanics. Circulation 2011 123 4 374 380 2-s2.0-79751532388 10.1161/CIRCULATIONAHA.110.976613
11. Beckie T. M., Groër M. W., Beckstead J. W., The relationship between polymorphisms on chromosome 9p21 and age of onset of coronary heart disease in black and white women. Genetic Testing and Molecular Biomarkers 2011 15 6 435 442 2-s2.0-79959248017 10.1089/gtmb.2010.0222
12. Saade S., Cazier J.-B., Ghassibe-Sabbagh M., Youhanna S., Badro D. A., Kamatani Y., Hager J., Yeretzian J. S., El-Khazen G., Haber M., Salloum A. K., Douaihy B., Othman R., Shasha N., Kabbani S., Bayeh H. E., Chammas E., Farrall M., Gauguier D., Platt D. E., Zalloua P. A., Large scale association analysis identifies three susceptibility loci for coronary artery disease. PLoS ONE 2011 6 12 2-s2.0-84455169865 10.1371/journal.pone.0029427 e29427
13. Lee J. Y., Lee B. S., Shin D. J., A genome-wide association study of a coronary artery disease risk variant. Journal of Human Genetics 2013 58 3 120 126 10.1038/jhg.2012.124
14. Qi L., Li J. M., Sun H., Huang X. Q., Lin K. Q., Chu J. Y., Yang Z. Q., Association between gene polymorphisms and myocardial infarction in Han Chinese of Yunnan province. Chinese Journal of Medical Genetics 2012 29 4 413 419
15. Gransbo K., Almgren P., Sjogren M., Smith J. G., Engstrom G., Hedblad B., Melander O., Chromosome 9p21 genetic variation explains 13% of cardiovascular disease incidence but does not improve risk prediction. Journal of Internal Medicine 2013 274 3 233 240 10.1111/joim.12063
16. Buysschaert I., Carruthers K. F., Dunbar D. R., Peuteman G., Rietzschel E., Belmans A., Hedley A., De Meyer T., Budaj A., Van De Werf F., Lambrechts D., Fox K. A. A., A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE genetics study. European Heart Journal 2010 31 9 1132 1141 2-s2.0-77952055198 10.1093/eurheartj/ehq053
17. Virani S. S., Brautbar A., Lee V.-V., Elayda M., Morrison A. C., Grove M. L., Nambi V., Frazier L., Wilson J. M., Willerson J. T., Boerwinkle E., Ballantyne C. M., Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circulation Journal 2012 76 4 950 956 2-s2.0-84858981200 10.1253/circj.CJ-11-1166
18. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 6 499 502 2-s2.0-0015348189
19. Gensini G. G., A more meaningful scoring system for determining the severity of coronary heart disease. The American Journal of Cardiology 1983 51 3 606 2-s2.0-0020701346 (Pubitemid 13187192)
20. Tseng L. N., Tseng Y. H., Jiang Y. D., Chang C. H., Chung C. H., Lin B. J., Chuang L. M., Tai T. Y., Sheu W. H., Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009. Journal of the Formosan Medical Association 2012 111 11 625 636 10.1016/j.jfma.2012.09.010
21. Broadbent H. M., Peden J. F., Lorkowski S., Goel A., Ongen H., Green F., Clarke R., Collins R., Franzosi M. G., Tognoni G., Seedorf U., Rust S., Eriksson P., Hamsten A., Farrall M., Watkins H., Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Human Molecular Genetics 2008 17 6 806 814 2-s2.0-40549109924 10.1093/hmg/ddm352 (Pubitemid 351359697)
22. Silander K., Tang H., Myles S., Jakkula E., Timpson N. J., Cavalli-Sforza L., Peltonen L., Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease. Genome Medicine 2009 1 5, article 51 2-s2.0-77952329135 10.1186/gm51
23. Holdt L. M., Beutner F., Scholz M., Gielen S., Gäbel G., Bergert H., Schuler G., Thiery J., Teupser D., ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 3 620 627 2-s2.0-77649166974 10.1161/ATVBAHA.109.196832
24. Motterle A., Pu X., Wood H., Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells. Human Molecular Genetics 2012 21 18 4021 4029 10.1093/hmg/dds224
25. Cunnington M. S., Koref M. S., Mayosi B. M., Burn J., Keavney B., Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression. PLoS Genetics 2010 6 4 2-s2.0-77952363272 10.1371/journal. pgen.1000899 e1000899
26. Kuo C.-L., Murphy A. J., Sayers S., Li R., Yvan-Charvet L., Davis J. Z., Krishnamurthy J., Liu Y., Puig O., Sharpless N. E., Tall A. R., Welch C. L., Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 11 2483 2492 2-s2.0-80054951104 10.1161/ATVBAHA.111.234492
27. Chen S. N., Ballantyne C. M., Gotto A. M. Jr., Marian A. J., The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis. BMC Cardiovascular Disorders 2009 9, article 3 2-s2.0-60849130127 10.1186/1471-2261-9-3
28. Peng W. H., Lu L., Zhang Q., Zhang R. Y., Wang L. J., Yan X. X., Chen Q. J., Shen W. F., Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese. Clinical Chemistry and Laboratory Medicine 2009 47 8 917 922 2-s2.0-70349512029 10.1515/CCLM.2009.215
29. Canto J. G., Kiefe C. I., Rogers W. J., Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the National Registry of Myocardial Infarction). The American Journal of Cardiology 2012 110 9 1256 1261 10.1016/j.amjcard.2012.06.025
30. Reriani M. K., Flammer A. J., Jama A., Lerman L. O., Lerman A., Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome. Circulation Journal 2012 76 4 778 783 2-s2.0-84858983984 10.1253/circj.CJ-12-0248
31. Liang K.-W., Lee W.-J., Lee W.-L., Ting C.-T., Sheu W. H.-H., Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis. Clinica Chimica Acta 2009 405 1-2 114 118 2-s2.0-67349200810 10.1016/j.cca.2009.04.018
32. Arsenault B. J., Barter P., Demicco D. A., Bao W., Preston G. M., Larosa J. C., Grundy S. M., Deedwania P., Greten H., Wenger N. K., Shepherd J., Waters D. D., Kastelein J. J. P., Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers. Journal of the American College of Cardiology 2010 57 1 63 69 2-s2.0-78650526061 10.1016/j.jacc.2010.06.052
33. Baruch A., van Bruggen N., Kim J. B., Lehrer-Graiwer J. E., Anti-inflammatory strategies for plaque stabilization after acute coronary syndromes. Current Atherosclerosis Reports 2013 15 6 327 10.1007/s11883-013- 0327-7
34. Chen L. Y., Sotoodehnia N., Buzkova P., Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study. JAMA Internal Medicine 2013 173 1 29 35 10.1001/2013.jamainternmed.744
35. Tung P., Albert C. M., Causes and prevention of sudden cardiac death in the elderly. Nature Reviews Cardiology 2013 10 3 135 142 10.1038/nrcardio.2012. 201
36. Janssens A. C. J. W., van Duijn C. M., Genome-based prediction of common diseases: advances and prospects. Human Molecular Genetics 2008 17 2 R166 R173 2-s2.0-57649243614 10.1093/hmg/ddn250
37. Ardissino D., Berzuini C., Merlini P. A., Mannuccio Mannucci P., Surti A., Burtt N., Voight B., Tubaro M., Peyvandi F., Spreafico M., Celli P., Lina D., Notarangelo M. F., Ferrario M., Fetiveau R., Casari G., Galli M., Ribichini F., Rossi M. L., Bernardi F., Marziliano N., Zonzin P., Mauri F., Piazza A., Foco L., Bernardinelli L., Altshuler D., Kathiresan S., Italian Atherosclerosis, Thrombosis and Vascular Biology Investigators I. A. T. A. V. B., Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction. Journal of the American College of Cardiology 2011 58 4 426 434 2-s2.0-80053316001
38. Muhlestein J. B., Anderson J. L., The 9p21.3 genetic region and coronary heart disease where do we go from here? Journal of the American College of Cardiology 2011 58 4 435 437 2-s2.0-80053337798
39. Marian A. J., The enigma of genetics etiology of atherosclerosis in the post-GWAS era. Current Atherosclerosis Reports 2012 14 4 295 299 2-s2.0-84858602671 10.1007/s11883-012-0245-0
40. McCarthy M. I., Abecasis G. R., Cardon L. R., Goldstein D. B., Little J., Ioannidis J. P. A., Hirschhorn J. N., Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews Genetics 2008 9 5 356 369 2-s2.0-42349112088 10.1038/nrg2344 (Pubitemid 351556063)
41. Patel R. S., Su S., Neeland I. J., Ahuja A., Veledar E., Zhao J., Helgadottir A., Holm H., Gulcher J. R., Stefansson K., Waddy S., Vaccarino V., Zafari A. M., Quyyumi A. A., The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease. European Heart Journal 2010 31 24 3017 3023 2-s2.0-78650316598 10.1093/eurheartj/ehq272
42. Hoppmann P., Erl A., Türk S., Tiroch K., Mehilli J., Schömig A., Kastrati A., Koch W., No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents. JACC: Cardiovascular Interventions 2009 2 11 1149 1155 2-s2.0-70449464762 10.1016/j.jcin.2009.08.021
43. Cavender M. A., Alexander K. P., Broderick S., Shaw L. K., McCants C. B., Kempf J., Ohman E. M., Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease. American Heart Journal 2009 158 6 933 940 2-s2.0-70649094029 10.1016/j.ahj.2009.10.013
44. Wilkinson P., Sayer J., Laji K., Grundy C., Marchant B., Kopelman P., Timmis A. D., Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study. British Medical Journal 1996 312 7042 1330 1333 2-s2.0-0029974388 (Pubitemid 26158303)
45. Zaman M. J., Bhopal R. S., New answers to three questions on the epidemic of coronary mortality in south Asians: incidence or case fatality? Biology or environment? Will the next generation be affected? Heart 2013 99 3 154 158 10.1136/heartjnl-2012-302364
46. Koh A. S., Khin L. W., Choi L. M., Sim L. L., Chua T. S., Koh T. H., Tan J. W., Chia S., Percutaneous coronary intervention in asians- are there differences in clinical outcome? BMC Cardiovascular Disorders 2011 11, article 22 2-s2.0-79956205487 10.1186/1471-2261-11-22
47. Goliasch G., Kleber M. E., Richter B., Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score. European Heart Journal 2012 33 18 2282 2289 10.1093/eurheartj/ehs164
48. Wen C. P., Tsai S. P., Chung W.-S. I., A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Annals of Internal Medicine 2008 148 4 258 267 2-s2.0-40049109862 (Pubitemid 351688355)
49. De Henauw S., De Smet P., Aelvoet W., Kornitzer M., De Backer G., Misclassification of coronary heart disease in mortality statistics. Evidence from the WHO-MONICA Ghent-Charleroi study in Belgium. Journal of Epidemiology and Community Health 1998 52 8 513 519 2-s2.0-0031660061 (Pubitemid 28408172)